Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Alert
Watchlist
Astrazeneca Pharma India
₹9,121.50
-101.00 (1.10%) 1D
Create Stock SIPAutomate your investments in this
Performance
Open
9,222.50Prev. Close
9,222.50Volume
8,696Total traded value
7.93 CrUpper Circuit
10,945.50Lower Circuit
7,297.50Fundamentals
| Market Cap | ₹23,052Cr |
| ROE | 22.72% |
| P/E Ratio(TTM) | 125.73 |
| EPS(TTM) | 73.34 |
| P/B Ratio | 29.92 |
| Dividend Yield | 0.35% |
| Industry P/E | 40.33 |
| Book Value | 308.14 |
| Debt to Equity | 0.05 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Astrazeneca Pharma India
AstraZeneca Pharma India is a science-led pharmaceutical firm focused on the research, development, and commercialization of prescription medicines for patients globally. The company's purpose is to push the boundaries of science, accelerating the delivery of life-changing treatments that create enduring value for all. Globally, its COVID-19 vaccine is credited with having saved more than six million lives, highlighting its significant impact on public health.;
| Parent Organisation | Astrazeneca Pharma India |
| Managing Director | Mr. Sanjeev Panchal |
| NSE Symbol | ASTRAZEN |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 43.84 | ||
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 49.05 | ||
| Pfizer | NA (0.00%) | 31.28 | ||
| Sanofi India | NA (0.00%) | 27.35 |